50BA.STU Bicycle Therapeutics PLC

- EUR
Market cap
-
P/E
-
P/B
0.51x
ROE
-43.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 50BA.STU undervalued?

Graham number

The Graham number of Bicycle Therapeutics PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bicycle Therapeutics PLC fundamental analysis

No fundamental analysis for Bicycle Therapeutics PLC yet.

Bicycle Therapeutics PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.